BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28487377)

  • 21. Optical Coherence Tomography Biomarkers of the Outer Blood-Retina Barrier in Patients with Diabetic Macular Oedema.
    Damian I; Nicoara SD
    J Diabetes Res; 2020; 2020():8880586. PubMed ID: 33110922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of changes of macular thickness in diabetic retinopathy after cataract surgery.
    Kwon SI; Hwang DJ; Seo JY; Park IW
    Korean J Ophthalmol; 2011 Aug; 25(4):238-42. PubMed ID: 21860569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy.
    Mikhail M; Stewart S; Seow F; Hogg R; Lois N
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1411-1418. PubMed ID: 29779188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.
    Kim SJ; Equi R; Bressler NM
    Ophthalmology; 2007 May; 114(5):881-9. PubMed ID: 17275910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years.
    Fusi-Rubiano W; Mukherjee C; Lane M; Tsaloumas MD; Glover N; Kidess A; Denniston AK; Palmer HE; Manna A; Morjaria R
    BMC Ophthalmol; 2018 Feb; 18(1):62. PubMed ID: 29486754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy.
    Chae JB; Joe SG; Yang SJ; Lee JY; Sung KR; Kim JY; Kim JG; Yoon YH
    Retina; 2014 Jan; 34(1):149-56. PubMed ID: 23807186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema.
    ; Baker CW; Almukhtar T; Bressler NM; Glassman AR; Grover S; Kim SJ; Murtha TJ; Rauser ME; Stockdale C
    JAMA Ophthalmol; 2013 Jul; 131(7):870-9. PubMed ID: 23599174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes and diabetic retinopathy in patients undergoing cataract surgery: a prevalence study-DiCat study report #2.
    Rossi T; Panozzo G; Della Mura G; Giannarelli D; Ferrari D; Alessio G; Palmisano C; Telani S; Ripandelli G
    Acta Diabetol; 2020 Jun; 57(6):645-650. PubMed ID: 31912329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optical coherence tomography angiography analysis of the choriocapillary layer in treatment-naïve diabetic eyes.
    Yang J; Wang E; Zhao X; Xia S; Yuan M; Chen H; Zhang X; Chen Y
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1393-1399. PubMed ID: 31089870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema.
    Lang GE; Liakopoulos S; Vögeler J; Weiß C; Spital G; Gamulescu MA; Lohmann C; Wiedemann P
    Acta Ophthalmol; 2018 May; 96(3):e377-e385. PubMed ID: 29090846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Cataract Surgery during Treatment with Ranibizumab in Patients with Diabetic Macular Edema.
    Moshfeghi AA; Shapiro H; Lemmon LA; Gune S
    Ophthalmol Retina; 2018 Feb; 2(2):86-90. PubMed ID: 31047350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subfoveal choroidal thickness in patients with diabetic retinopathy and diabetic macular oedema.
    Rewbury R; Want A; Varughese R; Chong V
    Eye (Lond); 2016 Dec; 30(12):1568-1572. PubMed ID: 27518549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema.
    Alkuraya H; Kangave D; Abu El-Asrar AM
    Int Ophthalmol; 2005 Jun; 26(3):93-9. PubMed ID: 17063373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up.
    Romero-Aroca P; de la Riva-Fernandez S; Valls-Mateu A; Sagarra-Alamo R; Moreno-Ribas A; Soler N; Puig D
    BMC Ophthalmol; 2016 Aug; 16():136. PubMed ID: 27491545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central retinal thickness assessment in a real life setting after cataract surgery in diabetic patients.
    Denier C; Fajnkuchen F; Giocanti-Aurégan A
    J Fr Ophtalmol; 2018 Dec; 41(10):904-909. PubMed ID: 30470488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early DMO: a predictor of poor outcomes following cataract surgery in diabetic patients. The DICAT-II study.
    Panozzo G; Mura GD; Franzolin E; Giannarelli D; Albano V; Alessio G; Arrigo A; Casati S; Cassottana P; Contardi C; D'Aloisio R; Fasce F; Gusson E; Marchini G; Mastropasqua L; Niccolò M; Palmisano C; Pastore MR; Saviano S; Tognetto D; Bandello F
    Eye (Lond); 2022 Aug; 36(8):1687-1693. PubMed ID: 34345028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fasting plasma glucose variability is an independent risk factor for diabetic retinopathy and diabetic macular oedema in type 2 diabetes: An 8-year prospective cohort study.
    Hsieh YT; Hsieh MC
    Clin Exp Ophthalmol; 2020 May; 48(4):470-476. PubMed ID: 32065699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy: The DIabetes and CATaract study.
    Panozzo G; Staurenghi G; Dalla Mura G; Giannarelli D; Alessio G; Alongi S; Appolloni R; Baldascino A; Boscia F; Caporossi A; Cereda M; D'Ugo E; Fallico M; Avitabile T; Galan A; La Spina C; Lo Giudice G; Mastropasqua L; Palmisano C; Panico C; Parravano MC; Penna R; Pintore P; Vaiano A; Reibaldi M; Rizzo S; Rossi T; Varano M; Virgili G
    Eur J Ophthalmol; 2020 Mar; 30(2):315-320. PubMed ID: 30854895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk for developing vision-threatening retinopathy after cataract surgery in diabetic patients depends on the postoperative follow-up time.
    Bek T; Tilma K; la Cour M
    Acta Ophthalmol; 2022 May; 100(3):e719-e725. PubMed ID: 34339106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early phacoemulsification in diabetic cataract for early recognition and management of diabetic macular oedema.
    Wahab S; Faiz-ur-Rab K; Das Hargun L
    J Coll Physicians Surg Pak; 2013 Jun; 23(6):401-4. PubMed ID: 23763799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.